Last update : 07/15/2014 | Version : 1 | ID : 60134
General | |
Identification | |
Detailed name | National Study on Prostate Cancer |
Sign or acronym | PROGENE |
CNIL registration number, number and date of CPP agreement, AFSSAPS (French Health Products Safety Agency) authorisation | CNIL: 27/06/2001 |
General Aspects | |
Medical area |
Cancer research |
Health determinants |
Genetic Social and psychosocial factors |
Others (details) | Prostate cancer |
Keywords | anatomopathological, data, weight, height, Health episodes, clinical, family history |
Scientific investigator(s) (Contact) | |
Name of the director | Cussenot |
Surname | Olivier |
Address | 75020 PARIS |
Phone | + 33 (0)1 56 01 64 95 |
olivier.cussenot@tnn.aphp.fr | |
Unit | CEREPP |
Organization | APHP |
Collaborations | |
Funding | |
Funding status |
Mixed |
Details | AP-HP CEREPP |
Governance of the database | |
Sponsor(s) or organisation(s) responsible | CEREPP |
Organisation status |
Private |
Additional contact | |
Main features | |
Type of database | |
Type of database |
Study databases |
Study databases (details) |
Cohort study |
Database recruitment is carried out by an intermediary |
A selection of health institutions and services |
Database recruitment is carried out as part of an interventional study |
No |
Additional information regarding sample selection. | Inclusion method: Prospective Other bodies active in creating this cohort: CHU, CHG, INDEPENDENT PHYSICIANS, CNAM |
Database objective | |
Main objective | General objective: To initiate a collection of informative families with at least one member with prostate cancer and apparently health subjects. Secondary objectives: - To identify genes for predisposition and susceptibility to prostate cancer - To identify genetic markers associated with recurrence after treatment - To develop a genetic screening test for these pathologies |
Inclusion criteria | Men with histologically verified prostate cancer Healthy subjects with PSA levels below 4 ng/ml |
Population type | |
Age |
Adulthood (19 to 24 years) Adulthood (25 to 44 years) Adulthood (45 to 64 years) |
Population covered |
Sick population |
Gender |
Male |
Geography area |
National |
Detail of the geography area | France |
Data collection | |
Dates | |
Date of first collection (YYYY or MM/YYYY) | 06/2001 |
Size of the database | |
Size of the database (number of individuals) |
[1000-10 000[ individuals |
Details of the number of individuals | 5965 |
Data | |
Database activity |
Data collection completed |
Type of data collected |
Clinical data Declarative data Biological data |
Clinical data (detail) |
Direct physical measures Medical registration |
Declarative data (detail) |
Paper self-questionnaire |
Biological data (detail) | Type of samples taken: Blood and/or saliva and/or urine |
Presence of a biobank |
Yes |
Contents of biobank |
Serum DNA |
Details of biobank content | Serum bank, DNA bank |
Health parameters studied |
Health event/morbidity Health event/mortality |
Procedures | |
Data collection method | Self-administered questionnaire: Entry from a paper questionnaire (Manual input) Clinical examination: Handwritten (Manual input) Biological Analysis: Handwritten (Manual input) |
Participant monitoring |
Yes |
Details on monitoring of participants | (Indefinite duration) |
Links to administrative sources |
No |
Promotion and access | |
Promotion | |
Link to the document | http://www.ncbi.nlm.nih.gov/pubmed/?term |
Access | |
Terms of data access (charter for data provision, format of data, availability delay) | Data may be used by academic teams. Access based on contract collaboration. Data may not be used by industrial teams |
Access to aggregated data |
Access on specific project only |
Access to individual data |
Access on specific project only |
Partners - FAQ - Contact - Site map - Legal notices - Administration - Updated on December 15 2020 - Version 4.10.05